Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study

Coronavirus disease 2019 (COVID-19) increases the risk of coagulopathy. Although the presence of antiphospholipid antibodies (aPLs) has been proposed as a possible mechanism of COVID-19-induced coagulopathy, its clinical significance remains uncertain. Therefore, this study aimed to evaluate the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Najim, Mostafa, Rahhal, Alaa, Khir, Fadi, Aljundi, Amer Hussien, Abu Yousef, Safae, Ibrahim, Feryal, Amer, Aliaa, Mohamed, Ahmed S., Saleh, Samira, Alfaridi, Dekra, Mahfouz, Ahmed, Alyafei, Sumaya, Howady, Faraj, Khatib, Mohamad, Alemadi, Samar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Observational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098785/
https://www.ncbi.nlm.nih.gov/pubmed/33954813
http://dx.doi.org/10.1007/s00296-021-04875-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098785/
https://www.ncbi.nlm.nih.gov/pubmed/33954813
http://dx.doi.org/10.1007/s00296-021-04875-7

Ejemplares similares